Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: NUMIF ) 0.0359 +0.0034 (+10.46%) Streaming Delayed Price Updated: 2:06 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about NUMIF Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031 July 26, 2023 EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END Via FinancialNewsMedia Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing July 14, 2023 Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Small Cap Growth Virtual Investor Conference Agenda Announced for July 13th July 10, 2023 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Numinus Expands Research Capabilities with new Phoenix Clinical Research Site February 17, 2023 The Phoenix Site is Numinus’ Third Research Facility in the US VANCOUVER, BC, Feb. 17, 2023 – Numinus Wellness Inc. (“Numinus”) (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing... Via PressReach Numinus Wellness Inc. Reports Q1 2023 Results January 17, 2023 Q1 2023 revenues grew 618% year-over-year to $5.7 million Q1 2023 gross margin grew to 41.9% from 31.5% in prior quarter Gross profit of $2.4 million, an increase of $1.1 million from prior quarter... Via PressReach KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing December 16, 2022 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th December 13, 2022 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research December 08, 2022 New clinical trial will provide experiential training to therapists learning to conduct psilocybin-assisted therapy. Clinical trial dosing will use Numinus Bioscience’s Psilocybin Tea, EnfiniTea – one... Via PressReach Numinus Wellness Inc. Reports Q4 2022 and Annual Results November 30, 2022 Q4 2022 revenues grew 643% year-over-year to $4.2 million Q4 2022 gross margin grew to 31.5%, generated $1.3 million of gross profit Completed acquisition of Novamind, positioning Numinus as a leading,... Via PressReach Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness October 28, 2022 a documentary following the journey of a patient undergoing psychedelic-assisted therapy to treat end-of-life distress. Additionally, since Numinus' Via PressReach New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences October 05, 2022 A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effects as a near-death experience (NDE). The... Via PressReach Topics Supply Chain Exposures Supply Chain Colorado to Vote on Legalizing Psychoactives in November October 05, 2022 Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the... Via PressReach Topics Supply Chain Exposures Supply Chain Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease October 05, 2022 A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll... Via PressReach Topics Cannabis Exposures Cannabis New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences October 05, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking... Via FinancialNewsMedia Mental Health Claims up 75% Since 2019 September 23, 2022 Canadian health insurers processed nearly $600 million in mental health service claims in 2021, up 75% from 2019 as more Canadians tapped into their mental health benefits. According to the Canadian... Via PressReach Mental Health Claims up 75% Since 2019 September 23, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 23, 2022 – Canadian health insurers processed nearly $600 million in mental health service claims in 2021, up 75%... Via FinancialNewsMedia Numinus Opens New Clinic in Montreal to Increase Access to Ketamine Therapy for Mental Health September 22, 2022 Mental healthcare company Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF) is focused on helping people heal by developing and delivering innovative treatments and safe, evidence-based... Via PressReach Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics September 22, 2022 Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... Via PressReach Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics September 22, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... Via FinancialNewsMedia Psychedelics Use Among Young Adults Reaches All-Time High September 01, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,... Via FinancialNewsMedia World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health June 15, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a... Via FinancialNewsMedia American Billionaire Entrepreneurs Bet Millions on Psychedelics May 10, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman... Via FinancialNewsMedia Exposures Product Safety Roth Capital Reveals Top Psychedelic Picks in New Industry Report April 21, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report... Via FinancialNewsMedia Demand for Toad Venom Rises Along With the Booming Psychedelics Market March 30, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic... Via FinancialNewsMedia Psilocybin and MDMA Get the Green Light for Medical Use in Canada January 19, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of... Via FinancialNewsMedia Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies December 16, 2021 Palm Beach, FL –December 16, 2021 – FinancialNewsMedia.com News Commentary – Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing... Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.